Business Context and Reporting Period
Company: Aprea Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 8, 2025
Reporting Period: Single event date (September 8, 2025)
This filing serves as a notification that the company updated its corporate presentation slide deck. The presentation is filed as Exhibit 99.1 and incorporated by reference.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing regarding an update to corporate materials and does not contain financial statements or performance data.
Material Changes
No material changes to financial position or operations are reported in this document. The only reported event is the update of the corporate presentation deck.
Guidance, Outlook, and Risks
Management Commentary: The filing contains no direct management commentary, guidance, or outlook. Any such information would be contained within the attached Exhibit 99.1 (Corporate Presentation), which is not included in the text of this filing.
Risks and Contingencies: No specific risks or contingencies are disclosed in this 8-K text.
Investor Verification Checklist
- Review Exhibit 99.1 (Corporate Presentation) for updated strategic guidance, clinical trial timelines, or financial projections.
- Verify if the updated presentation contains new information regarding the company's cash runway or capital requirements.
- Check subsequent filings for any material changes to the company's business strategy implied by the updated presentation.